Comparison of the effects of subinhibitory concentrations of ciprofloxacin and colistin on the morphology of cardiolipin domains in Escherichia coli membranes

Journal of Medical Microbiology

Volumn 61, Issue 4, 2012, Pages 520-524

  Kicia, Marta ^a   Janeczko, Natalia ^a   Lewicka, Jagoda ^a   Hendrich, Andrzej B ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; CARDIOLIPIN; CIPROFLOXACIN; COLISTIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FLUORESCENT DYE;

ARTICLE; BACTERIAL MEMBRANE; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINOACRIDINES; ANTI-INFECTIVE AGENTS; CARDIOLIPINS; CELL MEMBRANE; CIPROFLOXACIN; COLISTIN; ESCHERICHIA COLI; FLUORESCENT DYES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, FLUORESCENCE; STAINING AND LABELING;

EID: 84858111843     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.037788-0     Document Type: Article

References (24)

1. CLSI (2006). Performance Standards for Antimicrobial Susceptibility Testing, 16th edn, Informational Supplement M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
2. Dougherty, T. J. & Saukkonen, J. J. (1985). Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli. Antimicrob Agents Chemother 28, 200-206.
3. Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61, 377-392.
4. Drlica, K., Malik, M., Kerns, R. J. & Zhao, X. (2008). Quinolonemediated bacterial death. Antimicrob Agents Chemother 52, 385-392.
5. Epand, R. M. & Epand, R. F. (2009). Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788, 289-294.
6. Haines, T. H. & Dencher, N. A. (2002). Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett 528, 35-39.
7. Kawai, F., Shoda, M., Harashima, R., Sadaie, Y., Hara, H. & Matsumoto, K. (2004). Cardiolipin domains in Bacillus subtilis Marburg membranes. J Bacteriol 186, 1475-1483.
8. Kwa, A. L., Tam, V. H. & Falagas, M. E. (2008). Polymyxins: a review of the current status including recent developments. Ann Acad Med Singapore 37, 870-883.
9. Lobasso, S., Saponetti, M. S., Polidoro, F., Lopalco, P., Urbanija, J., Kralj-Iglic, V. & Corcelli, A. (2009). Archaebacterial lipid membranes as models to study the interaction of 10-N-nonyl acridine orange with phospholipids. Chem Phys Lipids 157, 12-20.
10. Mason, D. J., Power, E. G., Talsania, H., Phillips, I. & Gant, V. A. (1995). Antibacterial action of ciprofloxacin. Antimicrob Agents Chemother 39, 2752-2758.
11. Matsumoto, K., Kusaka, J., Nishibori, A. & Hara, H. (2006). Lipid domains in bacterial membranes. Mol Microbiol 61, 1110-1117.
12. Mileykovskaya, E. & Dowhan, W. (2000). Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye 10-N-nonyl acridine orange. J Bacteriol 182, 1172-1175.
13. Mileykovskaya, E. & Dowhan, W. (2005). Role of membrane lipids in bacterial division-site selection. Curr Opin Microbiol 8, 135-142.
14. Mileykovskaya, E., Ryan, A. C., Mo, X., Lin, C. C., Khalaf, K. I., Dowhan, W. & Garrett, T. A. (2009). Phosphatidic acid and Nacylphosphatidylethanolamine form membrane domains in Escherichia coli mutant lacking cardiolipin and phosphatidylglycerol. J Biol Chem 284, 2990-3000.
15. Miller, I. R., Bach, D. & Teuber, M. (1978). Effect of polymyxin B on the structure and the stability of lipid layers. J Membr Biol 39, 49-56.
16. Mortensen, N. P., Fowlkes, J. D., Sullivan, C. J., Allison, D. P., Larsen, N. B., Molin, S. & Doktycz, M. J. (2009). Effects of colistin on surface ultrastructure and nanomechanics of Pseudomonas aeruginosa cells. Langmuir 25, 3728-3733.
17. Petit, J. M., Maftah, A., Ratinaud, M. H. & Julien, R. (1992). 10-N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209, 267-273.
18. Petit, J. M., Huet, O., Gallet, P. F., Maftah, A., Ratinaud, M. H. & Julien, R. (1994). Direct analysis and significance of cardiolipin transverse distribution in mitochondrial inner membranes. Eur J Biochem 220, 871-879.
19. Romantsov, T., Helbig, S., Culham, D. E., Gill, C., Stalker, L. & Wood, J. M. (2007). Cardiolipin promotes polar localization of osmosensory transporter ProP in Escherichia coli. Mol Microbiol 64, 1455-1465.
20. Tamayo, M., Santiso, R., Gosalvez, J., Bou, G. & Fernández, J. L. (2009). Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol 9, 69.
21. Tucker, A. N. & White, D. C. (1970). Heterogeneity of phospholipid composition in the bacterial membrane. J Bacteriol 102, 508-513.
22. Unoson, C. & Wagner, E. G. (2008). A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol Microbiol 70, 258-270.
23. Wickens, H. J., Pinney, R. J., Mason, D. J. & Gant, V. A. (2000). Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure. Antimicrob Agents Chemother 44, 682-687.
24. Wojnicz, D., Kłak, M., Adamski, R. & Jankowski, S. (2007). Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains. Folia Microbiol (Praha) 52, 429-436.